{"id":"nct:NCT04526990","kind":"trial","title":"Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above","authors":["CanSino Biologics Inc."],"author_count":1,"year":2020,"published":"2020-08-26","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT04526990","source_url":"https://clinicaltrials.gov/study/NCT04526990","archive_url":"https://space-kitty.com/papers/nct:NCT04526990","updated":"2023-06-15","pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":"This study is a global multicenter, randomized, double-blind, placebo -controlled, adaptive designed phase Ⅲ clinical trial, in order to evaluate the efficacy, safety and immunogenicity of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in adults 18 years old and above.","abstract_license":"ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters","license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["COVID-19"],"details":{"acronym":null,"status":"COMPLETED","phase":"PHASE3","study_type":"INTERVENTIONAL","enrollment":44247,"sponsor":"CanSino Biologics Inc.","conditions":["COVID-19"],"interventions":["BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)","BIOLOGICAL: Placebo"],"start_date":"2020-09-15","start_date_type":"ACTUAL","primary_completion_date":"2021-08-07","has_results":false,"data_source":"ClinicalTrials.gov","data_processed":"2026-10-29T09:00:05","modifications":"selected fields only; whitespace normalized; brief summary truncated to 2,000 characters"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.","topics":[{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","domain_slug":"medicine"}],"cited_in_dossiers":[]}